Hospital-based clinical research is operating under growing pressure, as study protocols increase in complexity and operational performance is assessed with greater scrutiny across timelines, data quality, coordination and regulatory compliance. Consequently, clinical trial outsourcing is increasingly part of how institutions respond to this shift.
Table of Contents
This pressure is especially visible in healthcare institutions that aim to expand their research activity while working within rigid organisational structures. A recent interview with Susana Saraiva, coordinator of the Research and Innovation Centre at the Local Health Unit (ULS) of Loures-Odivelas, offers a useful point of reference. In this case, growth in clinical trial activity followed a deliberate effort to restructure processes and reinforce operational capacity.
This experience reflects a broader pattern across hospital-based research settings, where increases in activity depend on how effectively studies are coordinated and delivered. Within this context, clinical trial outsourcing emerges as a structural lever for institutions seeking to strengthen execution and expand their capacity to participate in increasingly demanding clinical programmes.
The growing pressure on hospital-based clinical research
Hospital-based clinical research is developing within a markedly more demanding operational environment. Sponsors now assess sites with close attention to responsiveness and the ability to support complex protocols. Therefore, the conditions for participating in clinical programmes have become more stringent, particularly for institutions whose research activity depends on broader hospital structures and administrative systems.
This shift has practical consequences. Research units are expected to manage feasibility processes quickly, coordinate study activation with greater precision and maintain reliable performance throughout the execution of the trial.
The experience described by Susana Saraiva offers a concrete illustration of this pressure. In the interview, she links the unit’s growth in clinical trial activity to a deliberate reorganisation of processes, with a focus on streamlining contractual procedures and reinforcing operational capacity. The coordinator also highlights that the likelihood of being selected for new studies depends in part on how quickly centres handle feasibilities, respond to selection questionnaires and progress contractual workflows.
In this challenging context, clinical trial outsourcing is increasingly used to strengthen execution capacity and support more responsive execution models in hospital-based research.
Where operational bottlenecks emerge in clinical trial execution
In this area, operational bottlenecks emerge across multiple stages of the trial lifecycle, often reinforcing each other and limiting the ability of research units to respond consistently to execution requirements. Identifying where these constraints occur is essential to improving performance and understanding where clinical trial outsourcing can have the greatest impact.
Limited access to specialised human resources
Access to specialised human resources remains a structural constraint in hospital-based research. Clinical trial execution depends on roles such as study coordinators, project managers and professionals with experience in regulatory and contractual workflows, which are difficult to recruit and retain within standard hospital frameworks.
We are unable to hire human resources, and even less so specialised professionals with expertise in contractual processes and clinical project management, which are highly specific fields. It is very difficult to attract this type of expertise, and companies like VectorB2B are therefore critical for us to progress and to increase our productivity. Without this support, it would not be possible.
Contractual complexity and legal constraints
Contractual processes represent a critical point in study activation, particularly in hospital environments where legal review involves multiple stakeholders and formal validation steps. Delays at this stage can extend timelines and directly influence whether a site remains eligible for participation.
In practice, contract turnaround times have become a decisive factor in site selection, linking legal efficiency to overall execution performance.
Administrative burden
Clinical trial operations are also affected by the accumulation of administrative processes across feasibility assessments and internal approvals. When these steps are not aligned, delays become structural and reduce the ability of research units to operate within expected timelines. In this context, clinical trial outsourcing contributes by introducing more structured workflows and reducing the administrative load on internal teams, supporting more consistent and predictable delivery.
Clinical trial outsourcing as a structural response in hospital settings
As clinical research activity expands within hospital environments, reinforcing execution capacity becomes a practical priority. In many cases, this requires introducing additional layers of operational support that can respond to specific constraints without overloading internal structures.
Clinical trial outsourcing enables research units to reinforce key execution areas while integrating with existing teams and workflows. Its impact is typically concentrated across four operational dimensions:
- Reducing contractual timelines and administrative friction: specialised support in contractual processes enables faster negotiation cycles and smoother progression from study selection to activation;
- Accessing specialised roles without internal hiring constraints: research units can integrate experienced profiles in coordination and project support, expanding capacity without relying on complex recruitment processes;
- Strengthening operational coordination and process consistency: structured support across workflows helps maintain alignment between feasibility, preparation and execution stages, improving responsiveness over time;
- Supporting funding strategy and project expansion: access to expertise in project development and funding applications supports the expansion of research activity and participation in more demanding programmes.
The evolving role of specialised partners in clinical research ecosystems
As highlighted by Susana Saraiva, “only through innovation, whether therapeutic or process-driven, can we improve the quality of care delivered to patients. Without research and innovation, there is no progress in healthcare. What we do must be recognised as a strategic priority within hospitals and healthcare centres if we are to achieve better health outcomes”.
Positioning research as a strategic priority also implies ensuring the conditions for its consistent execution. This perspective reflects a broader shift in how clinical research is integrated within healthcare institutions, where activity is increasingly understood as a core component of care improvement. In this context, external partners contribute with operational expertise that supports more structured and predictable study management.
VectorB2B operates within this framework, supporting healthcare institutions across different stages of clinical development. Through specialised services and integrated support, it enables research units to strengthen execution capacity and respond more effectively to the operational requirements of clinical trials.
Contact our team to explore how this approach can support your research activities.
Frequently asked questions (FAQ)
1. When is the right time for a hospital to consider clinical trial outsourcing?
When internal capacity begins to affect response times, study initiation or the ability to manage multiple trials. This often coincides with growth in activity without a corresponding increase in specialised resources. At this stage, clinical trial outsourcing supports further expansion.
2. How can outsourcing models be integrated without disrupting internal clinical teams?
Institutions should prioritise operational experience and expertise in contractual and regulatory processes. The ability to provide specialised support and adapt to different stages of development is also important. In clinical trial outsourcing, integration and consistency are key indicators of a reliable partner.
3. What criteria should institutions use to select a clinical research partner?
Without structured support, studies may face protocol deviations, inconsistent data, regulatory challenges and delays in timelines.
VectorB2B Articles
Insights and analysis across the life sciences ecosystem, from research and development to regulatory, operational and strategic frameworks.
Find something interesting?
Share it with your peers!
Article topics
Explore other articles
